SCHEMBL9911965

SCHEMBL9911965

NC(=O)CSSc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.47
HSD17B10 Q99714 3/20 0.47
FFAR1 O14842 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.44
HPGD P15428 1/20 0.44
MGLL Q99685 1/20 0.44
CXCL12 P48061 1/20 0.41
SIRT1 Q96EB6 1/20 0.40
RAB9A P51151 1/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2C19 P33261 2/20 0.38
TSHR P16473 2/20 0.38
POLB P06746 1/20 0.38
PARP1 P09874 1/20 0.38
RECQL P46063 1/20 0.38
BLM P54132 1/20 0.38
PMP22 Q01453 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
ALDH1A1 P00352 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4884474 0.83 FFAR1 (0.61) MAPTHSD17B10FFAR1SMN1; SMN2HPGD
SCHEMBL1170312 0.78 FFAR1 (0.68) MAPTHSD17B10FFAR1SMN1; SMN2CXCL12
Urea SCHEMBL27863158 0.77 HPGD (0.67) MAPTHSD17B10FFAR1SMN1; SMN2HPGD
Hydrochloric Acid SCHEMBL3043801 0.77 FFAR1 (0.65) MAPTHSD17B10FFAR1SMN1; SMN2CXCL12
Carbamic Acid SCHEMBL27979510 0.75 HPGD (0.63) MAPTHSD17B10FFAR1SMN1; SMN2HPGD
SCHEMBL2327183 0.73 ALPI (0.39) MAPTHSD17B10FFAR1SMN1; SMN2HPGD
SCHEMBL21367554 0.73 ALPI (0.39) MAPTHSD17B10FFAR1SMN1; SMN2HPGD
SCHEMBL1395738 0.72 ALDH1A1 (0.57) MAPTHSD17B10FFAR1SMN1; SMN2HPGD
SCHEMBL5204601 0.72 RAB9A (0.47) MAPTHSD17B10SMN1; SMN2RAB9APOLB
SCHEMBL445286 0.72 EHMT2 (0.53) MAPTHSD17B10SMN1; SMN2HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8198020-B2 Contacting target cell or noncellular molecular entity with phagocytic marker and moiety that binds to a component that is present on or at surface of target cell or noncellular molecular entity, thereby increasing level or density of phagocytic marker on target cell; marker comprises phosphatidylserine POTENTIA PHARMACEUTICALS, INC. (US) 2012-06-12 US disclosed